NEW YORK, Sept. 20, 2004 (PRIMEZONE) -- Home Solutions Health (Pink Sheets:HSHL): Hemorrelief, the patented, FDA-approved hemorrhoid treatment, and the Howard Stern Radio Show will hold an on-air open-call competition for the owner of the "World's Largest Hemorrhoid." Hemorrelief will reward a $10,000 prize to the winner of the contest. The contest is expected to receive participants from across the country.
Hemorrelief seeks to educate as well as reward: The contest will also feature a digestive disorder specialist on hand who will diagnose the hemorrhoids and dispense advice on their causes.
Since its launch in mid-June the Hemorrelief brand has worked to increase awareness about the prevalence of hemorrhoids and break down the stigma associated with the common ailment. "The World's Largest Hemorrhoid" competition will actually reward hemorrhoid sufferers for coming forward.
About Hemorrelief:
Hemorrelief was launched in mid-June of 2004 on the Howard Stern Show is quickly becoming one of the most talked about products to enter the marketplace and hit the radio waves. Since its launch, Hemorrelief has seen phenomenal sales, received unsolicited on-air testimonials and has found a devoted pitchman in KROCK jock and Stern Show regular Crazy Cabbie.
Hemorrelief, is strictly available in select physicians offices, via A 24-hour, toll free, hotline (1-888 HEM KOOL), and on their website (www.hemorrelief.com).
Home Solutions Health, Inc. is traded under the symbol HSHL on the pink sheets. Any forward-looking statements in this report are made pursuant to the ``safe harbor'' provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, continued acceptance of the company's products, increased levels of competition for the company, new products and technological changes, the company's dependence upon third-party suppliers, intellectual property rights and other risks detailed from time to time in the company's periodic reports filed with the Securities and Exchange Commission.